These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
808 related items for PubMed ID: 19323046
1. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia. Deris ZZ, Harun A, Shafei MN, Rahman RA, Johari MR. Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046 [Abstract] [Full Text] [Related]
3. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital. Alp E, Esel D, Yildiz O, Voss A, Melchers W, Doganay M. Scand J Infect Dis; 2006 Jan; 38(5):335-40. PubMed ID: 16709534 [Abstract] [Full Text] [Related]
4. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203 [Abstract] [Full Text] [Related]
5. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Baran G, Erbay A, Bodur H, Ongürü P, Akinci E, Balaban N, Cevik MA. Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154 [Abstract] [Full Text] [Related]
6. Epidemiology of and risk factors for Acinetobacter species bloodstream infection in children. Segal SC, Zaoutis TE, Kagen J, Shah SS. Pediatr Infect Dis J; 2007 Oct; 26(10):920-6. PubMed ID: 17901798 [Abstract] [Full Text] [Related]
7. Nosocomial bloodstream infections in ICU and non-ICU patients. Suljagić V, Cobeljić M, Janković S, Mirović V, Marković-Denić L, Romić P, Mikić D. Am J Infect Control; 2005 Aug; 33(6):333-40. PubMed ID: 16061139 [Abstract] [Full Text] [Related]
14. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine. Al Jarousha AM, El Jadba AH, Al Afifi AS, El Qouqa IA. Int J Infect Dis; 2009 Sep; 13(5):623-8. PubMed ID: 19144555 [Abstract] [Full Text] [Related]
15. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. Anunnatsiri S, Tonsawan P. Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949 [Abstract] [Full Text] [Related]
17. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome. Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N. J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198 [Abstract] [Full Text] [Related]
19. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. Poulakou G, Kontopidou FV, Paramythiotou E, Kompoti M, Katsiari M, Mainas E, Nicolaou C, Yphantis D, Antoniadou A, Trikka-Graphakos E, Roussou Z, Clouva P, Maguina N, Kanellakopoulou K, Armaganidis A, Giamarellou H. J Infect; 2009 Apr; 58(4):273-84. PubMed ID: 19344841 [Abstract] [Full Text] [Related]
20. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB. J Hosp Infect; 2004 Oct; 58(2):137-45. PubMed ID: 15474185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]